Tablet-based suicide-prevention program for adults 50–90 after hospital discharge
A Mobile Intervention for Suicide Prevention For Middle-aged And Older Adults After a Suicide-Related Hospitalization
A tablet app that teaches older adults simple emotion-control skills to help reduce suicidal thoughts after a hospital stay for suicidal ideation or an attempt.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11237576 on NIH RePORTER |
What this research studies
If you join, you would receive the WellPATH app on a tablet and short coaching to use personalized cognitive reappraisal techniques when strong negative emotions or urges arise. The program is mostly stand-alone and is used during emotionally charged moments and scheduled training sessions. The study compares a shorter (6-week) and a longer (12-week) version to see which best improves emotion regulation and lowers suicide risk. You would be assessed at hospital admission, at discharge, and at 6 and 12 weeks after discharge.
Who could benefit from this research
Good fit: Adults aged 50–90 who were recently hospitalized for suicidal ideation or a suicide attempt are the intended participants.
Not a fit: People under 50, those not recently hospitalized for suicide-related reasons, or individuals unable or unwilling to use a tablet may not benefit from this program.
Why it matters
Potential benefit: If successful, the program could help reduce suicidal thoughts and teach practical skills to manage intense negative emotions after hospital discharge.
How similar studies have performed: Emotion-regulation training and some digital interventions have shown promise, but mobile programs specifically for older adults after suicide-related hospitalization are relatively new and not yet widely proven.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Kiosses, Dimitris N — Weill Medical Coll of Cornell Univ
- Study coordinator: Kiosses, Dimitris N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.